Fig. 6: ICP-LncCRCTs are associated with cancer prognosis. | Communications Biology

Fig. 6: ICP-LncCRCTs are associated with cancer prognosis.

From: The landscape of immune checkpoint-related long non-coding RNAs core regulatory circuitry reveals implications for immunoregulation and immunotherapy responses

Fig. 6

a Radar plot representing the number of prognostic ICP-related lncRNAs in each type of cancer. b The radar plot represents the number of prognostically relevant ICP-LncCRCTs in each type of cancer. c Survival-related ICP-LncCRCTs as a percentage of total ICP-LncCRCTs in each cancer type. d Lollipop chart showing the numbers of cancer types in which the same survival-related ICP-LncCRCTs were found. e Nine ICP-LncCRCTs can be used as prognostic biomarkers in five cancer types. f Regulatory mechanism of MIR155HG/CXCL10/EBI3. g Forest plot of the MIR155HG/CXCL10/EBI3 risk score. The dashed line is the null line, indicating OR = 1. Each horizontal line indicates a 95% confidence interval. Squares indicate point estimates. h KM curves of the MIR155HG/CXCL10/EBI3-related genes in the high- and low-risk groups. Solid blue lines indicate high-risk groups, and solid yellow lines indicate low-risk groups. Shaded areas indicate 95% confidence intervals. Asterisks on the curves indicate censoring points. i The ability of MIR155HG/CXCL10/EBI3 to predict 1-, 3- and 5-year OS versus a single gene.

Back to article page